Alpha-1-antitrypsin (AAT) deficiency causes pulmonary disease due to decreased levels of circulating AAT and consequently unbalanced protease activity in the lungs. Deposition of specific AAT variants, such as the common Z AAT, within hepatocytes may also result in liver disease. These deposits are comprised of ordered polymers of AAT formed by an inter-molecular domain swap. The discovery and characterization of rare variants of AAT and other serpins have historically played a crucial role in the dissection of the structural mechanisms leading to AAT polymer formation. Here, we report a severely deficient shutter region variant, Bologna AAT (N186Y), which was identified in five unrelated subjects with different geographical origins. We cha...
Misfolding, polymerisation and defective secretion of functional α1-antitrypsin underlies the predis...
Alpha-1-antitrypsin (AAT) is an abundant glycoprotein in the plasma, is synthetized in the liver and...
Alpha(1)-antitrypsin is the most abundant circulating protease inhibitor. The severe Z deficiency al...
Alpha-1-antitrypsin (AAT) deficiency causes pulmonary disease due to decreased levels of circulating...
Alpha1-antitrypsin (AAT) deficiency is a hereditary disorder associated with reduced AAT plasma leve...
Alpha1-antitrypsin (AAT) deficiency is a hereditary disorder associated with reduced AAT plasma leve...
Alpha1-antitrypsin (AAT) deficiency is a hereditary disorder associated with reduced AAT plasma leve...
Alpha-1 antitrypsin deficiency (AATD) is an autosomal recessive disorder caused by mutations in the ...
Misfolding, polymerization, and defective secretion of functional alpha-1 antitrypsin underlies the ...
Alpha-1 antitrypsin deficiency (AATD) is an underdiagnosed disorder associated with mutations in the...
Severe alpha‐1‐antitrypsin deficiency (AATD) is most frequently associated with the alpha‐1‐antitryp...
Severe alpha-1-antitrypsin deficiency (AATD) is most frequently associated with the alpha-1-antitryp...
The SERPINA1 gene is highly polymorphic, with more than 100 variants described in databases. SERPINA...
Lung disease in alpha-1-antitrypsin deficiency (AATD) results from dysregulated proteolytic activity...
Lung disease in alpha-1-antitrypsin deficiency (AATD) results from dysregulated proteolytic activity...
Misfolding, polymerisation and defective secretion of functional α1-antitrypsin underlies the predis...
Alpha-1-antitrypsin (AAT) is an abundant glycoprotein in the plasma, is synthetized in the liver and...
Alpha(1)-antitrypsin is the most abundant circulating protease inhibitor. The severe Z deficiency al...
Alpha-1-antitrypsin (AAT) deficiency causes pulmonary disease due to decreased levels of circulating...
Alpha1-antitrypsin (AAT) deficiency is a hereditary disorder associated with reduced AAT plasma leve...
Alpha1-antitrypsin (AAT) deficiency is a hereditary disorder associated with reduced AAT plasma leve...
Alpha1-antitrypsin (AAT) deficiency is a hereditary disorder associated with reduced AAT plasma leve...
Alpha-1 antitrypsin deficiency (AATD) is an autosomal recessive disorder caused by mutations in the ...
Misfolding, polymerization, and defective secretion of functional alpha-1 antitrypsin underlies the ...
Alpha-1 antitrypsin deficiency (AATD) is an underdiagnosed disorder associated with mutations in the...
Severe alpha‐1‐antitrypsin deficiency (AATD) is most frequently associated with the alpha‐1‐antitryp...
Severe alpha-1-antitrypsin deficiency (AATD) is most frequently associated with the alpha-1-antitryp...
The SERPINA1 gene is highly polymorphic, with more than 100 variants described in databases. SERPINA...
Lung disease in alpha-1-antitrypsin deficiency (AATD) results from dysregulated proteolytic activity...
Lung disease in alpha-1-antitrypsin deficiency (AATD) results from dysregulated proteolytic activity...
Misfolding, polymerisation and defective secretion of functional α1-antitrypsin underlies the predis...
Alpha-1-antitrypsin (AAT) is an abundant glycoprotein in the plasma, is synthetized in the liver and...
Alpha(1)-antitrypsin is the most abundant circulating protease inhibitor. The severe Z deficiency al...